FEE AND MILESTONE PAYMENTS. 4.1 Initial Fee. In connection with the funding of research of Collaboration Product, Aventis shall pay to Avalon * within * of signing of this Agreement by the Parties, which amount is non-refundable and non-creditable.
Appears in 2 contracts
Sources: Collaboration and License Agreement (Avalon Pharmaceuticals Inc), Collaboration and License Agreement (Avalon Pharmaceuticals Inc)